Showing posts with label Nzérékoré Region. Show all posts
Showing posts with label Nzérékoré Region. Show all posts

Monday, 20 September 2021

Marburg Virus alert in Guinea comes to an end.

The Ministry of Health of Guinea has declared the end of the Marburg Virus Disease outbreak in Guéckédou Prefecture, Nzérékoré Region, according to a press release issued by the World Health Organization on 17 September 2021. In accordance with World Health Organization recommendations, the declaration was made 42 days after the safe and dignified burial of the only confirmed patient reported in this outbreak. This was the first-ever Marburg Virus Disease case reported in Guinea. 

On 16 September 2021, the Ministry of Health of Guinea declared the end of the Marburg virus disease outbreak in Guéckédou prefecture, Nzérékoré Region. In accordance with World Health Organization recommendations, the declaration was made 42 days after the safe and dignified burial of the only confirmed patient reported in this outbreak. This was the first-ever Marburg virus disease case reported in Guinea.

From 3 August 2021 to the end of outbreak declaration, only one confirmed case was reported.  The patient, a man, had onset of symptoms on 25 July. On 1 August he went to a small health facility near his village, with symptoms of fever, headache, fatigue, abdominal pain and gingival hemorrhage. A rapid diagnostic test for Malaria returned a negative result, and the patient received ambulatory supportive care with rehydration and symptomatic treatment. Upon returning home, his condition worsened, and he died on 2 August. An alert was subsequently raised by the sub-prefecture public health care facility to the prefectorial department of health in Guéckédou. The investigation team was immediately deployed to the village to conduct an in-depth investigation and collected a post-mortem oral swab sample, which was shipped on the same day to the Viral Hemorrhagic Fever Laboratory in Guéckédou city. On 3 August, the sample tested positive for Marburg Virus Disease by reverse transcriptase-polymerase chain reaction and negative for Ebola Virus Disease. The deceased patient was buried safely and with dignity on 4 August, with the support of the national Red Cross.

On 5 August, the National Reference Laboratory in Conakry provided confirmation by real-time polymerase chain reaction of the positive Marburg result, and on 9 August, the Institut Pasteur Dakar in Senegal provided an additional confirmation that the result was positive for Marburg Virus Disease and negative for Ebola Virus Disease.

 
Negative stained transmission electron micrograph of a number of filamentous Marburg Virions, which had been cultured on Vero cell cultures, and purified on sucrose, rate-zonal gradients. Erskine Palmer/Russell Regnery/Centers for Disease Control and Prevention/Wikimedia Commons.


The Ministry of Health activated the national and district emergency management committees to coordinate the response and engage with the community. Additionally, the Ministry of Health together with the World Health Organization, the United States Centers for Disease Control, the Alliance for International Medical Action, the Red Cross, UNICEF, the International Organization for Migration, and other partners, initiated measures to control the outbreak and prevent further spread including the implementation of contact tracing and active case search in health facilities and at the community level.

During the outbreak, a total of one confirmed case who died, and 173 contacts were identified, including 14 high risk contacts based on exposure. Among them, 172 were followed for a period of 21 days, of which none developed symptoms. One high-risk contact was lost to follow up. At the different points of entry in Guéckédou prefecture where passengers were screened, no alerts were generated.

Ongoing activities include:  Capturing and sampling of Bats in the localities of Temessadou M´Boké, Baladou Pébal and Koundou to better understand the involvement of Bats in the ecology of Marburg Viruses; development of a sero-surveillance protocol in the sub-prefecture of Koundou; development and implementation of plans to strengthen Infection Prevention and Control programmes at the national and facility level including establishing and mentoring of Infection Prevention and Control focal persons, Infection Prevention and Control/hygiene committees, ongoing training of health workers and adequate procurement and distribution of supplies such as personal protective equipment; implementation of water, sanitation and hygiene measures with partners including in health facilities and communities; supporting training on community-based surveillance in Guéckédou Prefecture; and risk communication and community mobilization activities in Guéckédou Prefecture as a component of a health emergency preparedness and response action plan. 

 
A health worker in Gueckedou, Guinea. World Health Organization.

Marburg Virus Disease is an epidemic-prone disease associated with high case fatality ratios (24-90%). In the early course of the disease, clinical diagnosis of Marburg Virus Disease is difficult to distinguish from many other tropical febrile illnesses, because of the similarities in the clinical symptoms. Other viral hemorrhagic fevers need to be excluded, particularly Ebola Virus Disease, as well as Malaria, Typhoid Fever, Leptospirosis, Rickettsial infection and Plague. Marburg Virus Disease is transmitted by direct contact with the blood, bodily fluids and/or tissues of infected persons or wild Animals (e.g. Monkeys and Fruit Bats).

Investigations are ongoing to identify the source of the infection. Guinea has previous experience in managing viral hemorrhagic diseases such as Ebola Virus Disease and Lassa Fever, but this was the first time that Marburg Virus Disease was reported. The country has a fragile health care system due to the overburden of disease outbreaks, COVID-19 pandemic, and the recurrent threat of epidemics such as Malaria, Yellow Fever, Measles, Lassa Fever, Ebola Virus Disease, health care-associated infections, high rates of acute malnutrition, cyclical natural disasters such as floods, and socio-political unrest.

Guinea health authorities responded rapidly to the event, and measures were rapidly implemented to control the outbreak. Cross-border population movement and community mixing between Guinea and neighboring Sierra Leone and Liberia increased the risk of cross-border spread. Sierra Leone and Liberia health authorities activated contingency plans and started public health measures at the points of entry with Guinea.

The affected village is in a remote forest area located at the border with Sierra Leone, about 9 km from a main international border crossing point between the two countries. The proximity of the affected area to an international border, cross-border movement between the affected district and Sierra Leone, and the potential transmission of the Virus between Bat colonies and Humans posed an increased risk for cross-border spread. 

These factors suggested a high risk at the national and regional level, and given that Guéckédou Prefecture is well connected to Foya District in Liberia, and Kailahun District in Sierra Leone, this outbreak required an immediate and coordinated response with support from international partners. The risk associated with the event at the global level was assessed as low. 

Human-to-Human transmission of Marburg virus is primarily associated with direct contact with blood and/or bodily fluids of infected persons, and Marburg Virus transmission associated with the provision of health care has been reported when appropriate infection control measures have not been implemented. 

Health care workers caring for patients with suspected or confirmed Marburg Virus Disease should apply standard and transmission-based infection prevention and control precautions to avoid any exposure to blood and/or bodily fluids, as well as unprotected contact with the possibly contaminated environment. Infection prevention and control precautions include: Early recognition (screening, triage) and isolation of suspected cases; appropriate isolation capacity (including infrastructure and human resources); health care workers’ access to hand hygiene resources (i.e., soap and water or alcohol-based hand rub); appropriate and accessible personal protective equipment for health care workers; safe infection practices (emphasise on single-use only needles); procedures and resources for decontamination and sterilisation of medical devices; and appropriate management of infectious waste.

Infection prevention and control  assessments of health facilities in affected areas using the Infection Prevention and Control Scorecard revealed sub-optimal results highlighting the need for ongoing supportive supervision and mentorship for implementation of infection prevention and control in health care settings in addition to implementing infection prevention and control minimum requirements to support and strengthen future preparedness for emerging and re-emerging infectious diseases. 

Integrated disease surveillance and response activities, including community-based surveillance must continue to be strengthened within all affected health zones.

Raising awareness of the risk factors for Marburg Virus Disease and the protective measures individuals can take to reduce human exposure to the virus are the key measures to reduce Human infections and deaths. Key public health communication messages include: Reducing the risk of Human-to-Human transmission in the community arising from direct contact with infected patients, particularly with their bodily fluids; avoiding close physical contact with patients who have Marburg Virus Disease; a ny suspected case ill at home should not be managed at home, but immediately transferred to a health facility for treatment and isolation. During this transfer, health care workers should wear appropriate personal protective eqipment; regular hand washing should be performed after visiting sick relatives in hospital; and communities affected by Marburg should make efforts to ensure that the population is well informed, both about the nature of the disease itself to avoid further transmission, community stigmatisation, and encourage early presentation to treatment centers and other necessary outbreak containment measures, including safe burial of the dead. People who have died from Marburg should be promptly and safely buried.

To reduce the risk of wildlife-to-Human transmissions, such as through contact with Fruit Bats, Monkeys, and Apes: Handle wildlife with gloves and other appropriate protective clothing; cook Animal products such as blood and meat thoroughly before consumption and avoid consumption of raw meat; and during work, research activities or tourist visits in mines or caves inhabited by Fruit Bat colonies, people should wear gloves and other appropriate protective clothing including masks.

See also...















Follow Sciency Thoughts on Facebook.

Follow Sciency Thoughts on Twitter


Saturday, 14 August 2021

Guinea reports the first ever case of Marburg Virus in West Africa.

Health authorities in Guinea have confirmed a case of Marburg Virus disease in Gueckedou Prefecture in the Nzérékoré Region of southern Guinea. This is the first time Marburg, a highly infectious disease that causes haemorrhagic fever, has been identified in the country, and in West Africa, according to a press release issued by the World Health Organization on 9 August 2021.

Marburg, which is in the same family as the virus that causes Ebola, was detected less than two months after Guinea declared an end to an Ebola outbreak that erupted earlier this year. Samples taken from a now-deceased patient and tested by a field laboratory in Gueckedou as well as Guinea’s National Haemorrhagic Fever Laboratory turned out positive for the Marburg virus. Further analysis by the Institut Pasteur in Senegal confirmed the result.

 
A health worker in Gueckedou, Guinea. World Health Organization.

The patient had sought treatment at a local clinic in Koundou area of Gueckedou, where a medical investigation team had been dispatched to probe his worsening symptoms.

'We applaud the alertness and the quick investigative action by Guinea’s health workers. The potential for the Marburg virus to spread far and wide means we need to stop it in its tracks,' said Matshidiso Moeti, the World Health Organization's Regional Director for Africa. 'We are working with the health authorities to implement a swift response that builds on Guinea’s past experience and expertise in managing Ebola, which is transmitted in a similar way.'

Gueckedou, where Marburg has been confirmed, is also the same region where cases of the 2021 Ebola outbreak in Guinea as well as the 2014–2016 West Africa outbreak were initially detected.

Efforts are underway to find the people who may have been in contact with the patient. As the disease is appearing for the first time in the country, health authorities are launching public education and community mobilisation to raise awareness and galvanize support to help curb widespread infection.

An initial team of 10 World Health Organization experts, including epidemiologists and socio-anthropologists is on the ground helping to investigate the case and supporting the national health authorities to swiftly step up emergency response, including risk assessment, disease surveillance, community mobilization, testing, clinical care, infection prevention as well as logistical support.

Cross-border surveillance is also being enhanced to quickly detect any cases, with neighbouring countries on alert. The Ebola control systems in place in Guinea and in neighbouring countries are proving crucial to the emergency response to the Marburg virus.

Marburg is transmitted to people from Fruit Bats and spreads among Humans through direct contact with the bodily fluids of infected people, surfaces and materials.

Illness begins abruptly, with high fever, severe headache and malaise. Many patients develop severe haemorrhagic signs within seven days. Case fatality rates have varied from 24% to 88% in past outbreaks depending on Virus strain and case management.

Although there are no vaccines or antiviral treatments approved to treat the virus, supportive care, rehydration with oral or intravenous fluids, and treatment of specific symptoms, improves survival. A range of potential treatments, including blood products, immune therapies and drug therapies, are being evaluated.

In Africa, previous outbreaks and sporadic cases have been reported in Angola, the Democratic Republic of the Congo, Kenya, South Africa and Uganda.

See also...














Follow Sciency Thoughts on Facebook.

Follow Sciency Thoughts on Twitter.
 

Friday, 26 February 2021

Ebola Virus Disease outbreak reported in Guinea.

A new outreak of Ebola Fever has been reported in Guinea, according to the World Health Organization. On 14 February 2021, the Ministry of Health of Guinea informed the World Health Organization of a cluster of Ebola Virus Disease cases in the sub-prefecture of Gouécké in the Nzérékoré Region of Guinea between 18 January and 13 February 2021. The cases showed symptoms of diarrhea, vomiting and bleeding after attending the burial of another relative (a 51 year-old nurse) on 1 February 2021.

The index case of the cluster was a nurse who had originally presented at a health centre in Gouécké on 18 January 2021 with headache, physical weakness, nausea, vomiting, loss of appetite, abdominal pain, and fever. She was diagnosed with Typhoid. She sought a second consultation at a health facility in Nzérékoré on 23 January 2021 for fever, vomiting, liquid stools, and physical weakness, and she was diagnosed with Malaria. On 24 January she consulted a traditional practitioner in Nzérékoré, and she died on 28 January 2021. She was buried unsafely on 1 February in Gouécké. The other six cases are the five family members and the traditional practitioner she visited. 

Among the seven cases, five have died (4 probable and 1 confirmed). The other two confirmed cases are currently in isolation in dedicated health care facilities in Conakry and Gouécké, Nzérékoré region.  

The Ebolavirus species has not yet been determined. Additional laboratory analyses are on-going to ascertain Virus species.  

As of 15 February, one hundred and ninety-two contacts have been identified, including 164 contacts in N’Zérékoré Health District and 28 in Ratoma Health District, Conakry. To date, no contacts have been reported to have travelled in neighboring countries. However, Nzérékoré is the second-largest city in Guinea and lies at the intersection of roads from Ganta (in Liberia), Danané (Côte d’Ivoire), and roads to other major hubs in Guinea like Kankan and Macenta in (Guinea). Therefore, there is concern about the exportation of Ebola Virus Disease cases into the neighbouring countries. 

On 14 February 2021, following the declaration of the Ebola Virus Disease outbreak, the Ministry of Health of Guinea convened a crisis meeting.

The Ministry of Health of Guinea, World Health Organization, and Global Outbreak Alert and Response Network partners, have initiated measures to control the outbreak and prevent further spread. To coordinate the response, the Ministry of Health activated the national and district emergency management committees. They also advised the public to take measures to avert the spread of the disease, and to report any persons with symptoms to seek care. Multidisciplinary teams have been deployed to the field to; actively search and provide care for cases, trace and follow-up contacts, and sensitize communities on infection prevention and control.

Ebola Virus Disease is caused by RNA Viruses of the genus Ebolavirus. It has a reputation for being the world's deadliest viral disease, at least in part due to the 1995 film Outbreak, though this is probably slightly inaccurate as about 50% of victims survive, making it less deadly than diseases such as Rabies. However, it is extremely contagious, with know known cure, and has a tendency to rapidly overwhelm local health systems as health workers themselves are infected.

 
Electron micrograph of an Ebola Virus particle. Frederick Murphy/Centers for Disease Control and Prevention/Wikimedia Commons.

Ebola begins with a fever similar to that caused by Influenza or Malaria, which tends to come on rapidly two-to-three weeks after infection (during at least part of which time the patient is already infectious). This tends to be followed by extreme respiratory tract infection, headaches, confusion, rashes and tissue necrosis and heavy bleeding. Death is generally caused by multiple organ failure.

The only known treatment for Ebola is intensive rehydration, which can improve the survival prospects of patients greatly, accompanied by anticoagulants and procoagulants to mange the diseases attacks on the circulatory system, analgesia to cope with the pain of the disease and antibiotics and antimycotics to prevent secondary infection. Due to the highly contagious nature of the disease it is recommended that healthcare workers wear full-body protection to maintain a barrier between them and their patients; a daunting prospect in the tropical regions of Africa where the disease is endemic. 

Ebolavirus is thought to have a non-human animal vector, since its rapid onset and high mortality rate appears to preclude a permanent residence within Human hosts. Surveys of wild animals have found Ebola infections in Rodents and Great Apes, however these were affected by the disease in a similar way to Humans, and are therefore unlikely permanent hosts. The most likely vectors are thought to be Fruit Bats or small Primates, which are endemic to the areas where the disease occurs and which are widely eaten; cooking meat probably kills the virus, but there is a distinct danger of infection while preparing carcasses.  

See also...













Follow Sciency Thoughts on Facebook.

Follow Sciency Thoughts on Twitter.